Czasopismo
Tytuł artykułu
Warianty tytułu
Języki publikacji
Abstrakty
The growth of solid tumours and their metastases is dependent on the development of new blood vessels (angiogenesis). Therefore angiogenesis inhibitors are potential antitumour drugs. In our previous studies it was found that the angiogenesis inhibitor TNP-470 given to transplantable melanoma-bearing hamsters can decrease the rate of the tumour growth, although the survival time of the animals treated was not significantly affected. It was found finally that TNP-470 given in the vicinity of the growing tumour can cause complete remission of the melanoma in hamsters treated in this way. To check what side-effects could be evoked by such treatment, an examination of the morphology of the blood vessels of the lungs, kidneys and livers of the treated animals was carried out. It was found that the angiogenesis inhibitor applied did not cause any changes which could be observed by light and electron microscopes in the structure of the examined blood vessels of the treated animals.
Słowa kluczowe
Twórcy
autor
- Medical University, Debinki 1, 80-210 Gdansk, Poland
autor
autor
autor
Bibliografia
- 1. Bhargava P, Marshall JL, Rizivi N, Dahut W, Yoe, Figuera M, Phipps K, Ong VS, Kato A, Hawkins (1999) A phase I and pharmacokinetic study of TNP-470 administrated weekly to patients with advanced cancer. Clin Cancer Res, 5: 1989–1995.
- 2. Bomirski A, Slominski A, Bigda J (1988) The natural history of a family of transplantable melanomas in hamsters. Cancer Metastasis Rev, 7: 95–118.
- 3. Castronovo V, Belotti D (1996) TNP-470 (AGM-1470): Mechanism of action and early clinical development. Eur J Cancer, 32A: 2520–2527.
- 4. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst, 82: 4–6.
- 5. Folkman J (1992) Tumor angiogenesis and tissue factor. Nature Med, 2: 167–168.
- 6. Gervaz P, Fontolliet M (1998) Therapeutic potential of the anti-angiogenesis drug TNP-470. Int J Exp Pathol, 79: 359–362.
- 7. Hotz HG, Reber HA, Hotz B, Sanghavi PC, Yu T, Foitzik T, Buhr HJ, Hines OJ (2001) Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth. J Gastrointest Surg, 5: 131–138.
- 8. Ingbar D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagilin that inhibit angiogenesis and suppress tumor growth. Nature, 348: 555–557.
- 9. Kusaka M, Sudo K, Matsutani E, Kozai Y, Marui S, Fujita T, Ingbar D, Folkman J (1994) Cytostatic inhibition of endothelial cell growth by angiogenesis inhibitor TNP-470 (AGM-1470). Br J Cancer, 69: 212–216.
- 10. Mahadevan V, Hart IR (1990) Matastasis and angiogenesis. Acta Oncol, 29: 97–103.
- 11. Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y, Hori H (2000) Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells. Int J Radiation Oncology Biol Phys, 47: 799–807.
- 12. Myśliwski A, Szmit E, Szatkowski D, Sosonowska D (1998) Suppression of growth of Bomirski Ab melanoma and its metastasis in hamsters by angiogenesis inhibitor TNP-470. Anticancer Res, 18: 441–444.
- 13. Myśliwski A, Bigda J, Koszałka P, Szmit E (2000) Synergistic effect of the agniogenesis inhibitor TNP-470 and Tumor Necrosis Factor (TNF) on Bomirski Ab melanoma in hamsters. Anticancer Res, 20: 4643–4648.
- 14. Myśliwski P, Koszałka P, Bigda J, Szmit E (2002) Complete remission of Bomirski Ab amelanotic melanoma in hamsters treated with the angiogenesis inhibitor TNP-470. Neoplasma, 49: 319–322.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-article-9dc041c4-ff6a-41f2-a16b-a9b2de6cfbc8